Dallas, TX -- (SBWIRE) -- 11/24/2010 -- SandlerResearch announce it will carry Huntington’s Disease - Pipeline Assessment and Market Forecasts to 2017 Market Research Report in its Store.
GlobalData, the industry analysis specialist, has released its new report, “Huntington’s Disease - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Huntington’s disease therapeutics market and pipeline. The report identifies the key trends shaping and driving the global huntington’s disease therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global muscular dystrophy therapeutics sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData has estimated the global Huntington’s disease therapeutics market to be valued at $142 m in 2009. It is expected to increase to $2 billion with a Compound Annual Growth Rate (CAGR) of 39.6 by 2017. There is a high unmet need in the current Huntington’s disease therapeutics market in terms of both safety and efficacy profile. New high potential drugs of Huntington’s disease therapeutics are expected to come in the market after 2017.
Scope
The report provides information on the key drivers and challenges of the Huntington’s disease therapeutics market. Its scope includes:
- Annualized global Huntington’s disease therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major classes such as nerve growth factor and doparmegenic neurons loss inhibitor
- Analysis of the current and future competition in the global Huntington’s disease therapeutics market. Key market players covered are Amarin Corporation and Medivation Inc.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Huntington’s disease therapeutics market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Huntington’s disease therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Huntington’s disease market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Huntington’s disease market landscape? – Identify, understand and capitalize.
Browse complete Report on: Huntington’s Disease - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/41251-huntingtons-disease-pipeline-assessment-and-market-forecasts-t.html
1 Table of Contents 3
1.1 List of Tables 4
1.2 List of Figures 4
2 Huntington’s Disease: Market Characterization 5
2.1 Overview 5
2.2 Huntington’s Disease Therapeutics Market Size 6
2.3 Huntington’s Disease Market Forecast and CAGR 7
2.4 Drivers and Barriers for the Huntington’s Disease Therapeutics Market 8
2.4.1 Drivers for the Huntington’s Disease Therapeutics Market 8
2.4.2 Barriers for the Huntington’s Disease market 8
2.5 Opportunity and Unmet Need 8
2.6 Key Takeaway 10
3 Huntington’s Disease Therapeutics Market: Competitive Assessment 11
3.1 Overview 11
3.2 Strategic Competitor Assessment 11
3.3 Product Profile for the Major Marketed Products in the Huntington’s Disease Therapeutics Market 12
3.3.1 Xenazine (tetrabenazine) 12
3.4 Key Takeaway 13
4 Huntington’s Disease: Pipeline Assessment 14
4.1 Overview 14
4.2 Strategic Pipeline Assessment 14
4.2.1 Technology Trends Analytic Framework 14
4.3 Huntington’s Disease Therapeutics – Promising Drugs under Clinical Development 16
4.4 Molecule Profile for Promising Drugs under Clinical Development 17
4.4.1 AMR-101 (Miraxion, ethyl EPA) (Amarin Pharmaceuticals) 17
4.4.2 Dimebon (latrepirdine) (Medivation/Pfizer) 18
4.4.3 Coenzyme Q10 (CoQ) (National Institute of Neurological Disorders and Stroke - NINDS) 19
4.5 Huntington’s Disease Therapeutics– Clinical Pipeline by Mechanism of Action 20
4.5.1 Huntington’s Disease TherapeuticsPipeline – Pipeline by Clinical Phases of Development 21
4.5.2 Huntington’s Disease Therapeutics – Phase III Clinical Pipeline 21
4.5.3 Huntington’s Disease Therapeutics – Phase II Clinical Pipeline 21
4.5.4 Huntington’s Disease Therapeutics – Phase I Clinical Pipeline 22
4.5.5 Huntington’s Disease Therapeutics – Preclinical Phase Pipeline 22
4.5.6 Huntington’s Disease Therapeutics – Discovery Pipeline 22
4.6 Key Takeaway 23
5 Huntington’s Disease Therapeutics Market: Implications for Future Market Competition 24
6 Huntington’s Disease Therapeutics Market: Future Players in the Huntington’s Disease Market 26
6.1 Introduction 26
6.2 Amarin Corporation, Ireland 27
6.2.1 Overview 27
6.2.2 CNS Portfolio 27
6.2.3 Huntington’s disease Portfolio 27
6.3 Medivation Inc., the US 28
6.3.1 Overview 28
6.3.2 CNS Portfolio 29
6.3.3 Huntington’s Disease Portfolio 29
6.4 National Institute of Neurological Disorders and Stroke, the US 30
6.4.1 Overview 30
6.4.2 Huntington’s Disease Portfolio 30
7 Huntington’s Disease Market: Appendix 32
7.1 Market Definitions 32
7.2 Abbreviations 32
7.3 Research Methodology 33
7.3.1 Coverage 33
7.3.2 Secondary Research 34
7.3.3 Forecasting 34
7.3.4 Primary Research 37
7.3.5 Expert Panel Validation 37
7.4 Contact Us 37
7.5 Disclaimer 37
7.6 Sources 38
Browse all Healthcare Market Research Reports on:
http://www.sandlerresearch.org/market-research/healthcare/
Browse all GlobalData Market Research Reports on
http://www.sandlerresearch.org/publishers/globaldata/
Browse all Newly Published Market Research Reports on:
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports:
Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/37204-peripheral-arterial-disease-pad-pipeline-assessment-and-marke.html
Alzheimer’s Disease - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/39674-alzheimers-disease-pipeline-assessment-and-market-forecasts-to.html
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/39675-amyotrophic-lateral-sclerosis-lou-gehrigs-disease-pipeline-a.html
Paget’s disease of Bone - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/41249-pagets-disease-of-bone-pipeline-assessment-and-market-forecast.html
Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
http://www.sandlerresearch.org/reports/16235-huntingtons-disease-drug-pipeline-analysis-and-market-forecast.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.com